Objective: To evaluate whether the developmental potential of the blastocyst is affected by the number of trophectoderm (TE) cells biopsied in preimplantation genetic diagnosis (PGD) cycles.
Design: Retrospective study.
Setting: University-affiliated center.
Patient(s): Women underwent PGD cycles of blastocyst biopsy and fluorescence in situ hybridization analysis.
Intervention(s): Not applicable.
Main outcome measure(s): Biopsied TE cell number of blastocysts, survival, and implantation rates.
Result(s): The biopsied TE cell number was affected by the TE quality and experience of different embryologists. The diagnostic efficiency increased when from one to five cells were biopsied (86.7%, 91.7%%, 96.0%, 96.8%, to 98.7%) and was maximized when more than six cells were biopsied. To compare the clinical efficiencies, blastocysts were divided into four groups according to biopsied TE cell number: 1-5, 6-10, 11-15, and 16-41. For the blastocysts with grade A TE score, no significant difference was observed in the survival and implantation rates among the four groups. For the blastocysts with grades B and C TE scores, the survival rates showed no significant differences among the four groups, but a significant decreasing trend in implantation rates was observed with increasing biopsied TE cell number.
Conclusion(s): The implantation potential is negatively affected by the biopsied TE cell number in blastocysts with poor TE morphological score.
Keywords: Blastocyst biopsy; biopsied cell number; implantation; trophectoderm quality.
Copyright © 2016 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.